HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population

BACKGROUND: The frequency of HER2 overexpression in bladder cancer is reported as 9%-61%. HER2 alteration correlates with aggressive disease in bladder cancer. Traditional anti-HER2 targeted therapy has failed to show clinical benefits in patients with advanced urothelial carcinoma . METHODS: The in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Shao, Zhiting, Liu, Yiqiang, Yan, Xieqiao, Li, Juan, Wu, Xiaowen, Tang, Bixia, Li, Siming, Cui, Chuanliang, Chi, Zhihong, Si, Lu, Kong, Yan, Mao, Lili, Lian, Bin, Wang, Xuan, Bai, Xue, Dai, Jie, Guo, Jun, Sheng, Xinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400138/
https://www.ncbi.nlm.nih.gov/pubmed/36971495
http://dx.doi.org/10.1093/oncolo/oyad070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400138/
https://www.ncbi.nlm.nih.gov/pubmed/36971495
http://dx.doi.org/10.1093/oncolo/oyad070

Ejemplares similares